This study tests a new gel-like material called Embrace Hydrogel Embolic that doctors inject through a thin tube into bleeding arteries. The gel blocks the bleeding vessel, aiming to stop blood loss without needing surgery or additional devices. The trial involves 130 adults with…
Phase: NA • Sponsor: Instylla, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC